- Home
- NBTX vs ESRT Comparison
NBTX vs ESRT Comparison
Compare NBTX & ESRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBTX | ESRT |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | NBTX | ESRT |
|---|---|---|
| Price | $20.30 | $6.56 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 1 | 1 |
| Target Price | ★ $8.00 | $6.80 |
| AVG Volume (30 Days) | 34.1K | ★ 1.3M |
| Earning Date | 09-30-2025 | 02-18-2026 |
| Dividend Yield | N/A | ★ 2.18% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | $11,930,711.00 | ★ $766,184,000.00 |
| Revenue This Year | N/A | $1.95 |
| Revenue Next Year | $145.24 | $2.89 |
| P/E Ratio | ★ N/A | $31.24 |
| Revenue Growth | N/A | ★ 1.02 |
| 52 Week Low | $2.82 | $6.36 |
| 52 Week High | $30.35 | $10.27 |
Technical Indicators
Market Signals| Indicator | NBTX | ESRT |
|---|---|---|
| Relative Strength Index (RSI) | 42.02 | 42.56 |
| Support Level | $21.67 | $6.36 |
| Resistance Level | $23.40 | $6.62 |
| Average True Range (ATR) | 0.98 | 0.14 |
| MACD | -0.27 | -0.00 |
| Stochastic Oscillator | 11.22 | 28.47 |
Price Performance
Historical ComparisonAbout NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About ESRT Empire State Realty Trust Inc.
Empire State Realty Trust operates as a pure-play greater New York and Manhattan-focused REIT, featuring its landmark Empire State Building office and observation deck. The company owns and operates around 8.5 million square feet of office space, about 80% of which is located in Manhattan.